Wednesday, June 10, 2026
Newsletter About
Business & Finance

GSK to buy US cancer biotech Nuvalent for $10.6bn

New chief Luke Miels makes his mark at GSK with one of UK drugmakers’ biggest deals

This article was originally published by Financial Times and is republished here under license.

New chief Luke Miels makes his mark at GSK with one of UK drugmakers’ biggest deals

More in Business & Finance

View All →

Leave a Reply

Discover more from The Meridian Review

Subscribe now to keep reading and get access to the full archive.

Continue reading